A limitation of our study is the lack of assessment of the potential key factors of the development of human NAFLD other than fibrosis, such as alteration in insulin signaling, intestinal barrier function, and/or Toll-like receptor-dependent signaling. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.